Skip to main content
Log in

Valproic acid—induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Gal P, Oles KS, Gilman JT, Weaver R (1988) Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures. Neurology 38(3):467–471

    Article  CAS  PubMed  Google Scholar 

  2. Clancy RR (2006) Summary proceedings from the neurology group on neonatal seizures. Pediatrics 117(3 Pt 2):S23–S27. doi:10.1542/peds.2005-0620D

    PubMed  Google Scholar 

  3. Alfonso I, Alvarez LA, Gilman J, Dunoyer C, Yelin K, Papazian O (2000) Intravenous valproate dosing in neonates. J Child Neurol 15(12):827–829

    Article  CAS  PubMed  Google Scholar 

  4. Uberall MA, Trollmann R, Wunsiedler U, Wenzel D (2000) Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 54(11):2188–2189

    Article  CAS  PubMed  Google Scholar 

  5. Yu KT, Mills S, Thompson N, Cunanan C (2003) Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 44(5):724–726

    Article  CAS  PubMed  Google Scholar 

  6. Tulloch JK, Carr RR, Ensom MH (2012) A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. J Pediatr Pharmacol Ther 17(1):31–44

    PubMed  PubMed Central  Google Scholar 

  7. Hermida J, Tutor JC (2005) A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients. J Pharmacol Sci 97(4):489–493

    Article  CAS  PubMed  Google Scholar 

  8. Lheureux PE, Penaloza A, Zahir S, Gris M (2005) Science review: carnitine in the treatment of valproic acid-induced toxicity—what is the evidence? Crit Care 9(5):431–440. doi:10.1186/cc3742

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ghodke-Puranik Y, Thorn CF, Lamba JK, Leeder JS, Song W, Birnbaum AK, Altman RB, Klein TE (2013) Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics 23(4):236–241. doi:10.1097/FPC.0b013e32835ea0b2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Price KE, Pearce RE, Garg UC, Heese BA, Smith LD, Sullivan JE, Kennedy MJ, Bale JF Jr, Ward RM, Chang TK, Abbott FS, Leeder JS (2011) Effects of valproic acid on organic acid metabolism in children: a metabolic profiling study. Clin Pharmacol Ther 89(6):867–874

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Sztajnkrycer MD (2002) Valproic acid toxicity: overview and management. J Toxicol Clin Toxicol 40(6):789–801

    Article  CAS  PubMed  Google Scholar 

  12. Silva MF, Aires CC, Luis PB, Ruiter JP, IJ L, Duran M, Wanders RJ, de Tavares AI (2008) Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J Inherit Metab Dis 31(2):205–216

    Article  CAS  PubMed  Google Scholar 

  13. Tseng YL, Huang CR, Lin CH, Lu YT, Lu CH, Chen NC, Chang CC, Chang WN, Chuang YC (2014) Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy. Medicine (Baltimore) 93(11):e66. doi:10.1097/MD.0000000000000066

    Article  CAS  Google Scholar 

  14. Nagy A, Budi T, Temesvari M, Szever Z, Szabo PT, Monostory K (2015) Adverse events in a newborn on valproate therapy due to loss-of-function mutations in CYP2C9. Epilepsy & behavior case reports 4:86–87

    Article  Google Scholar 

  15. Inoue K, Takahashi T, Yamamoto Y, Suzuki E, Takahashi Y, Imai K, Inoue Y, Hirai K, Tsuji D, Itoh K (2015) Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy. Seizure 33:76–80

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Pavla Pokorna is supported by the General University Hospital Project (MH CZ-DRO VFN 64165) (Ministry of Health, Czech Republic - Conceptual Development of Research Organization) (MH CZ–DRO, name of organization; VFN - General Faculty Hospital, name of institution), and an unrestricted research grant of the Intensive Care of the Erasmus MC-Sophia Childrens Hospital (name of institution).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pavla Pokorná.

Additional information

Dick Tibboel is the lead author of this paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pokorná, P., Hronová, K., Šíma, M. et al. Valproic acid—induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report. Eur J Clin Pharmacol 73, 647–649 (2017). https://doi.org/10.1007/s00228-017-2208-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-017-2208-4

Keywords

Navigation